Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene/Benzoyl Peroxide Gel in Acne Vulgaris
NCT00422240Phase 3Completed
- Sponsor
- Galderma
- Start
- Jun 2006
- Primary completion
- Jul 2007
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of adapalene + benzoyl peroxide in acne vulgaris (4 arms), sponsored by Galderma. Primary endpoints: Percentage of Participants Who Achieved Success Rate 0 (Clear) or 1 (Almost Clear) on the Investigator Global Assessment (IGA) Scale at 12 weeks, Change in Inflammatory Lesion Count From Baseline to Week 12 and 1 more. Started Jun 2006; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00422240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422240.